Skip to main content

Table 3 Baseline characteristics of the study population according to the METS-IR quartiles

From: Comparisons of three novel markers for insulin resistance to predict incident cardiovascular disease: a Korean cohort study from three different regions

Characteristics

Overall (n = 28,437)

Q1 (n = 7111)

Q2 (n = 7105)

Q3 (n = 7117)

Q4 (n = 7104)

P valuea

Post hocb

METS-IR

33.22 ± 7.10

 ≤ 27.84

27.85–32.67

32.68–37.92

 ≥ 37.93

  

Age (years)

47.6 ± 10.7

42.4 ± 8.2

47.1 ± 10.0

49.9 ± 10.6

50.9 ± 11.6

 < 0.001

a,b,c,d,e,f

Body mass index (kg/m2)

22.6 ± 3.9

18.0 ± 2.2

21.5 ± 1.7

23.8 ± 1.7

27.0 ± 2.5

 < 0.001

a,b,c,d,e,f

Male sex (%)

51.1

38.5

41.8

59.9

64.2

 < 0.001

–

Current smoker (%)

22.8

21.0

19.2

25.9

25.0

 < 0.001

–

Alcohol drinking (%)

34.5

42.4

32.2

31.5

31.7

 < 0.001

–

Systolic blood pressure (mmHg)

121.9 ± 16.8

113.6 ± 15.0

119.0 ± 15.9

124.7 ± 15.4

130.5 ± 15.9

 < 0.001

a,b,c,d,e,f

Diastolic blood pressure (mmHg)

77.4 ± 10.9

73.8 ± 11.2

75.3 ± 10.6

78.6 ± 10.1

81.9 ± 9.9

 < 0.001

a,b,c,d,e,f

Mean arterial pressure (mmHg)

92.2 ± 12.3

87.0 ± 11.7

89.8 ± 11.8

94.0 ± 11.3

98.1 ± 11.3

 < 0.001

a,b,c,d,e,f

Fasting plasma glucose (mg/dl)

94.0 ± 20.5

88.3 ± 14.1

91.4 ± 17.7

95.0 ± 19.2

101.2 ± 26.6

 < 0.001

a,b,c,d,e,f

Total cholesterol (mg/dl)

192.1 ± 35.2

188.5 ± 34.0

188.3 ± 34.1

193.0 ± 35.0

198.5 ± 36.9

 < 0.001

b,c,d,e,f

Triglyceride (mg/dl)

133.8 ± 97.0

99.5 ± 63.9

107.7 ± 73.7

132.0 ± 75.5

196.1 ± 129.2

 < 0.001

a,b,c,d,e,f

HDL-cholesterol (mg/dl)

52.1 ± 12.6

59.4 ± 14.0

55.6 ± 11.5

49.7 ± 9.5

43.5 ± 8.5

 < 0.001

a,b,c,d,e,f

C-reactive protein (mg/L)

1.1 ± 3.4

0.5 ± 1.9

0.9 ± 3.0

1.3 ± 4.1

1.6 ± 4.1

 < 0.001

a,b,c,d,e,f

eGFR (mL/min/1.73 m2)

86.8 ± 17.4

91.7 ± 19.0

87.4 ± 17.1

84.8 ± 16.1

83.4 ± 15.9

 < 0.001

a,b,c,d,e,f

Hypertension medication (%)

11.0

4.0

7.8

13.2

19.1

 < 0.001

–

Diabetes medication (%)

11.4

9.5

8.7

11.7

15.8

 < 0.001

–

Dyslipidemia medication (%)

2.3

0.7

1.5

2.8

4.2

 < 0.001

–

  1. aP values were calculated using 1-way ANOVA or chi-squared test
  2. bPost hoc analysis with the Bonferroni method: a, Q1 vs. Q2; b, Q1 vs. Q3; c, Q1 vs. Q4; d, Q2 vs. Q3; e, Q2 vs. Q4; and f, Q3 vs. Q4
  3. METS-IR: metabolic score for insulin resistance; HDL-C: High-density lipoprotein cholesterol; eGFR: estimated glomerular filtration rate